Idiopathic thrombocytopenic purpura : Current concepts in pathophysiology and managementSTASI, Roberto; EVANGELISTA, Maria Laura; STIPA, Elisa et al.Thrombosis and haemostasis. 2008, Vol 99, Num 1, pp 4-13, issn 0340-6245, 10 p.Article

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)AMADORI, Sergio; SUCIU, Stefan; THOMAS, Xavier et al.Journal of clinical oncology. 2013, Vol 31, Num 35, pp 4424-4430, issn 0732-183X, 7 p.Article

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemiaDEL POETA, Giovanni; AMMATUNA, Emanuele; PANETTA, Paola et al.British journal of haematology. 2010, Vol 149, Num 3, pp 383-387, issn 0007-1048, 5 p.Article

Novel role of triazenes in haematological malignancies : Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemiaCAPORASO, Patrizia; TURRIZIANI, Mario; BONMASSAR, Enzo et al.DNA repair. 2007, Vol 6, Num 8, pp 1179-1186, issn 1568-7864, 8 p.Article

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 TrialWILLEMZE, Roelof; SUCIU, Stefan; FABBIANO, Francesco et al.Journal of clinical oncology. 2014, Vol 32, Num 3, pp 219-228, issn 0732-183X, 10 p.Article

Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaO'BRIEN, Susan; RIZZIERI, David A; STAUDACHER, Karin et al.British journal of haematology. 2012, Vol 158, Num 5, pp 581-588, issn 0007-1048, 8 p.Article

Azacitidine for the Treatment of Lower Risk Myelodysplastic Syndromes: A Retrospective Study of 74 Patients Enrolled in an Italian Named Patient ProgramMUSTO, Pellegrino; MAURILLO, Luca; SPAGNOLI, Alessandra et al.Cancer. 2010, Vol 116, Num 6, pp 1485-1494, issn 0008-543X, 10 p.Article

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrowMAURILLO, Luca; BUCCISANO, Francesco; OTTAVIANI, Licia et al.Haematologica (Roma). 2007, Vol 92, Num 5, pp 605-611, issn 0390-6078, 7 p.Article

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemiaDEL POETA, Giovanni; DEL PRINCIPE, Maria Ilaria; BUCCISANO, Francesco et al.Expert review of anticancer therapy. 2006, Vol 6, Num 12, pp 1787-1800, issn 1473-7140, 14 p.Article

Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursorsMAURILLO, Luca; DEL POETA, Giovanni; PICARDI, Alessandra et al.Haematologica (Roma). 2001, Vol 86, Num 3, pp 237-243, issn 0390-6078Article

GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factorsLATAGLIATA, Roberto; BRECCIA, Massimo; MARTINELLI, Giovanni et al.British journal of haematology. 2011, Vol 154, Num 5, pp 564-568, issn 0007-1048, 5 p.Article

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)AMADORI, Sergio; SUCIU, Stefan; TORELLI, Giuseppe et al.British journal of haematology. 2010, Vol 149, Num 3, pp 376-382, issn 0007-1048, 7 p.Article

Consolidation and Maintenance Immunotherapy With Rituximab Improve Clinical Outcome in Patients With B-cell Chronic Lymphocytic LeukemiaDEL POETA, Giovanni; ILARIA DEL PRINCIPE, Maria; GATTEI, Valter et al.Cancer. 2008, Vol 112, Num 1, pp 119-128, issn 0008-543X, 10 p.Article

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaLO-COCO, Francesco; CIMINO, Giuseppe; VENDITTI, Adriano et al.Blood. 2004, Vol 104, Num 7, pp 1995-1999, issn 0006-4971, 5 p.Article

New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophiliaCOX, M. Christina; PANETTA, Paola; VENDITTI, Adriano et al.Leukemia research. 2001, Vol 25, Num 4, pp 349-351, issn 0145-2126Article

Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia : a pilot study from the Gimema GroupMONTILLO, Marco; TEDESCHI, Alessandra; MONACO, Michele et al.British journal of haematology. 2000, Vol 111, Num 1, pp 334-337, issn 0007-1048Article

Azacitidine for the Treatment of Patients With Acute Myeloid Leukemia*: Report of 82 Patients Enrolled in an Italian Compassionate ProgramMAURILLO, Luca; VENDITTI, Adriano; RENZO, Nicola Di et al.Cancer. 2012, Vol 118, Num 4, pp 1014-1022, issn 0008-543X, 9 p.Article

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)AMADORI, Sergio; STASI, Roberto; ROSSETTI, Elena et al.British journal of haematology. 2012, Vol 156, Num 2, pp 205-212, issn 0007-1048, 8 p.Article

A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemiasGRUSZKA, Alicja M; LAVORGNA, Serena; CEDRONE, Michele et al.Blood. 2010, Vol 116, Num 12, pp 2096-2102, issn 0006-4971, 7 p.Article

M4 acute myeloid leukemia : the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experiencePULSONI, Alessandro; LACOBELLI, Simona; LISO, Vincenzo et al.Haematologica (Roma). 2008, Vol 93, Num 7, pp 1025-1032, issn 0390-6078, 8 p.Article

Toward Optimization of Postremission Therapy for Residual Disease-Positive Patients With Acute Myeloid LeukemiaMAURILLO, Luca; BUCCISANO, Francesco; VENDITTI, Daniela et al.Journal of clinical oncology. 2008, Vol 26, Num 30, pp 4944-4951, issn 0732-183X, 8 p.Article

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemiaILARIA DEL PRINCIPE, Maria; DEL POETA, Giovanni; OTTAVIANI, Licia et al.Blood. 2006, Vol 108, Num 3, pp 853-861, issn 0006-4971, 9 p.Article

Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemiaCIMINO, Giuseppe; LO-COCO, Francesco; FIORINI, Roberto et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8903-8911, issn 0008-5472, 9 p.Article

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasBUCCISANO, Francesco; ROSSI, Francesca Maria; TAMBURINI, Anna et al.British journal of haematology. 2004, Vol 125, Num 2, pp 203-212, issn 0007-1048, 10 p.Article

Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosminOTTONE, Tiziana; ZAZA, Serena; CIARDI, Claudia et al.British journal of haematology. 2013, Vol 161, Num 4, pp 533-540, issn 0007-1048, 8 p.Article